Other grades of this product :
| Compound 2 Basic information |
| Product Name: | Compound 2 | | Synonyms: | Glucagon-Like Peptide 1 Receptor Agonist - CAS 281209-71-0 - Calbiochem;113683;Glucagon-Like Peptide 1 Receptor Agonist;2-Quinoxalinamine, 6,7-dichloro-N-(1,1-dimethylethyl)-3-(methylsulfonyl)-;6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline (DMB);Compound 2;GLP-1R agonist;GLP-1R agonist DMB | | CAS: | 281209-71-0 | | MF: | C13H15Cl2N3O2S | | MW: | 348.25 | | EINECS: | | Product Categories: | | Mol File: | 281209-71-0.mol |
| Compound 2 Chemical Properties |
| Boiling point | 535.2±50.0 °C(Predicted) | | density | 1.423±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: ≥10mg/mL | | pka | -0.94±0.59(Predicted) | | form | Yellow solid | | color | light brown-yellow |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 |
| Compound 2 Usage And Synthesis |
| General Description | Glucagon-like peptide-1 receptor (GLP-1R) agonist is a potential oral drug for modulating glucagon-like peptide (GLP)-1 in diabetic patients. GLP-1R agonists play a key role in lowering glycated hemoglobin levels. It improves glycemic control and maintenance of body weight. | | Biochem/physiol Actions | GLP-1R is a small molecule GLP-1 receptor agonist. GLP-1 receptor signaling is a predominant mechanism for regulating glucose homeostasis. This compound represents a unique non-peptide tool for studying the role of GLP-1 in both in vivo and in vitro diabetes and obesity models. |
| Compound 2 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye